About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Chicago | 351 Studies

Clinical Trials HypertensionChicago

Hypertension Clinical Trials in Chicago

Find 351 clinical trials for hypertension near Chicago, Illinois. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 261-280 of 351 trials

CompletedGastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver TransplantationThe rapid rise in obesity (body mass index (BMI) ≥ 30 kg/m2) in the US over the past decade is responsible for more disease and death than any other single factor.NCT02068872·Chicago, Illinois

Hypertension Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedChronic Sildenafil for Severe Diaphragmatic HerniaThe purpose of this study is to test if sildenafil is effective in the treatment of infants with severe congenital diaphragmatic hernia (determined by the presence of prolonged…NCT00133679·Los Angeles, California and 2 others

CompletedGlycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And HypertensionTo evaluate the effects of two different antihypertensive medications in the drug class of beta-blockers on control of glucose in Type II diabetic patients with high blood…NCT00060918·Glendale, Arizona and 49 others

CompletedSafety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionTo determine the effectiveness of four different strength combinations of three approved anti-hypertension therapies (olmesartan medoxomil, amlodipine, and hydrochlorothiazide)…NCT00649389·Birmingham, Alabama and 231 others

CompletedRetrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United StatesThe Opsumit Users registry (OPUS; NCT02126943) was developed to characterize the safety profile of Opsumit and to describe clinical characteristics and outcomes of patients newly…NCT03197688·Phoenix, Arizona and 105 others

Active not recruitingLEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFThis study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD…NCT05983250·Tucson, Arizona and 41 others

CompletedPredicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter AnalysisPrimary aldosteronism (PA) is the excessive endogenous production of the mineralocorticoid aldosterone.NCT04761354·San Francisco, California and 13 others

Completed12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes MellitusThis trial will evaluate safety and efficacy of BI 10773 in hypertensive patients with type 2 diabetes.NCT01370005·Huntsville, Alabama and 119 others

Enrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)Congenital Portosystemic Shunt (CPSS) is a rare condition important by the multiplicity and severity of associated complications.NCT06041906·New Haven, Connecticut and 25 others

CompletedSymptomatic Pulmonary Arterial Hypertension After Mitral Valve SurgeryMost patients with mitral valve disease are symptomatic with shortness of breath and a limited activity level prior to mitral valve surgery.NCT01646541·Chicago, Illinois and 1 other

CompletedPharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm PreeclampsiaThe purpose of the study is to assess the efficacy, safety and pharmacokinetics (PK) of recombinant human antithrombin (ATryn) in addition to expectant management for the…NCT02059135·Birmingham, Alabama and 22 others

CompletedIrbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionThe purpose of this clinical research is to learn if severe hypertension can be better controlled by initially treating with a combination of drugs (Irbesartan/HCTZ), in patients…NCT00095394·Birmingham, Alabama and 268 others

CompletedA Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled HypertensionThe main purpose of this study is to assess the serum free cortisol response after ACTH stimulation test at baseline and at Week 8 in participants with uncontrolled hypertension.NCT06336356·Phoenix, Arizona and 9 others

TerminatedExtended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGERThis extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with pulmonary hypertension (PH) who previously…NCT03068130·Phoenix, Arizona and 95 others

CompletedA Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication RegimenA Phase 2 trial to evaluate the blood pressure-lowering effect of lorundrostat an aldosterone synthase inhibitor (ASI), administered as an add-on to a standardized…NCT05769608·Birmingham, Alabama and 103 others

CompletedEffect of Azilsartan on Aldosterone in Postmenopausal FemalesThe purpose of the research is to evaluate the effect of azilsartan medoximil on blood pressure and urinary aldosterone levels in postmenopausal females.NCT01774591·Chicago, Illinois

CompletedA Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant HypertensionThis study assessed the blood pressure effect, safety and tolerability of LCI699 compared to placebo and eplerenone in participants with resistant hypertension.NCT00817635·Mobile, Alabama and 37 others

Active not recruitingA Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial HypertensionThe primary objective of this study is to assess the effect of early and rapid treprostinil therapy for mean pulmonary artery pressure (mPAP) reduction to improve right…NCT05203510·Phoenix, Arizona and 27 others

CompletedOpen-Label Rollover Study of Levosimendan in PH-HFpEF PatientsPH-HFpEF patients will receive open-label doses of levosimendan and be periodically evaluated for safety in extended use.NCT03624010·Stanford, California and 8 others

CompletedAn Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With HypertensionThis 14 week study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients 65 years of age or older with high blood pressure.NCT00412932·Birmingham, Alabama and 28 others

PreviousPage 14 of 18Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia